Hikma Pharma Launches Authorized Generic Version Of Xyrem In U.S.
Source: NASDAQ US Markets / 03 Jan 2023 03:15:34 America/New_York
(RTTNews) - Hikma Pharmaceuticals PLC said that it has launched an authorized generic version of Jazz Pharmaceuticals' Xyrem (sodium oxybate) oral solution CIII.
https://www.nasdaq.com/articles/hikma-pharma-launches-authorized-generic-version-of-xyrem-in-u.s.